QT 5 Inc. (OTC)

Seite 1 von 1
neuester Beitrag: 12.07.04 19:18
eröffnet am: 22.06.04 00:44 von: soros Anzahl Beiträge: 25
neuester Beitrag: 12.07.04 19:18 von: soros Leser gesamt: 1252
davon Heute: 1
bewertet mit 0 Sternen

22.06.04 00:44

4388 Postings, 7246 Tage sorosQT 5 Inc. (OTC)

Wer ist noch investiert? Wer weiß genau, wieviele Aktien die aktuell am Markt haben. Bei OTCBB steht was von 10 Mio Shares, an einer anderen Stelle steht wieder was von 20 Mio Shares outstanding?

OTC ist immer so eine Sache, aber so lange die nicht mit neuen Aktien verwässern, kann man sich ja noch Hoffnung machen. Ich bin nach dem Split reingegangen und überlege noch, einmal nachzukaufen? Letzten News unten. Schwer einzuschätzen, da OTC oftmals nur Betrügerbuden sind?



Börse NASDAQ OTC BBS  

Aktuell 0,027 USD  

Zeit 21.06.04  21:57  

Diff. Vortag +8,00 %  

Tages-Vol. 4.852,45  

Geh. Stück 163.580  



Geld 0,025  

Brief 0,03  

Zeit 21.06.04  21:49  

Spread 16,667%  

Geld Stk. 5.000  

Brief Stk. --  



Schluss
Vortag 0,025  

Eröffnung 0,027  

Hoch 0,036  

Tief 0,022  

52W Hoch --  

52W Tief --  

   
Split --



QT 5, Inc. Retains Equitilink LLC for Investor Relations
WESTLAKE VILLAGE, Calif., June 2, 2004 (PRIMEZONE) -- QT 5, Inc. (OTCBB:QTFI), manufacturer, distributor and marketer of biomedical products, today announced that it has retained Equitilink LLC of La Jolla, Calif. as its investor relations firm.

QT 5, Inc. President, Steven H. Reder said, "Our Company's corporate development and growth opportunities are at the point where it is appropriate to retain a sophisticated investor relations firm. We are impressed with Equitilink's broad and proactive relationship with investors who invest in micro cap stocks, and with the extensive and diverse experience of its executives. We believe it is the right firm to advise and assist QT 5, Inc. in our financial communications."

"We believe that QT 5, Inc. has the business plan and the management to succeed at introducing and marketing their full line of diagnostic and first-aid products. We look forward to advising and assisting the company on its financial communications and shareholder relations," said Jim Mahoney, Managing Director of Equitilink LLC. Investors interested in listening to Equitilink's plan for increasing shareholder value for QT 5, Inc. are encouraged to call Equitilink's Investor Service Representatives toll-free at 1-877-788-1940.

About QT 5, Inc.

QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing products. QT 5, Inc. is currently engaged in the development and introduction of Drug Stop, a rapid urinalysis test for drugs of abuse, FDA cleared for professional and over-the-counter use, as well as its Target System(tm) Diagnostic platform that tests for infectious diseases and medical conditions, FDA cleared for professional use only. In addition, the Company markets Xact Aid first-aid products for over-the-counter sales. The company continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: (www.qt5inc.com).

Safe Harbor

This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward-looking statements.

CONTACTS:  QT 5, Inc.
          Steve Reder
          President
          (818) 338-1510
          sreder@qt5inc.com

          Equitilink LLC
          Investor Relations
          (877) 788-1940 (toll-free)
 

22.06.04 00:48

4388 Postings, 7246 Tage sorosWatchliste aufnehmen erstmal!

WKN:A0BM03

...La Jolla...?  

22.06.04 01:12

4388 Postings, 7246 Tage sorosBabelfish

Quart 5, Inc. Retains Equitilink LLC für Beziehungen zwischen den Investoren WESTLAKE DORF, Calif., Juni 2, 2004 (PRIMEZONE) -- Quart 5, Inc. (OTCBB:QTFI), Hersteller, Verteiler und Marketingspezialist der biomedizinischen Produkte, verkündete heute, daß er Equitilink LLC von La Jolla, Calif behalten hat. wie seine Beziehungen zwischen den Investoren fest machen. Quart 5, Inc. Präsident, Steven H. gesagtes Reder, "Our Company's korporative Entwicklung und Wachstumgelegenheiten sind am Punkt, in dem es angebracht ist, ein hoch entwickeltes Beziehung zwischen den Investorenunternehmen zu behalten. Wir werden mit Equitilink's ausgedehntem und proaktivem Verhältnis zu den Investoren, die Mikrokappe auf Lager investieren, und zur umfangreichen und verschiedenen Erfahrung seiner Hauptleiter beeindruckt. Wir glauben, daß es das rechte Unternehmen ist, zum von von Quart 5, Inc. zu raten und zu unterstützen in unserem finanziellen communications." "We glauben, daß Quart 5, Inc. den Unternehmensplan und das Management, zum am Einführen und am Marketing zu folgen ihre volle Linie der Diagnose- und Erste-Hilfeprodukte hat. Wir freuen, die Firma auf seinen finanziellen Kommunikationen und Aktionärrelationen, " zu beraten und die Unterstützung; besagtes Jim Mahoney, geschäftsführender Geschäftsführer von Equitilink LLC. Die Investoren, die interessiert werden, an dem Hören zum Equitilink's Plan auf zunehmendem Aktionärwert auf Quart 5, Inc., angeregt werden, Equitilink's Investor-Techniker gebührenfrei zu nennen bei 1-877-788-1940. Über Quart 5, Inc.. Quart 5, Inc. ist eine Delaware Korporation, die im April 1999 als Hersteller, Verteiler und Marketingspezialist der Bio-Med prüfenprodukte gebildet wird. Quart 5, Inc. nimmt z.Z. an der Entwicklung und der Einleitung des Droge-Anschlags, ein schneller Urinalysistest für Drogen des Mißbrauches, die FDA teil, die für professionellen und im Freiverkehr gehandelten Gebrauch, sowie seine Ziel System(tm) Diagnoseplattform gelöscht wird, die Tests für ansteckende Krankheiten und medizinische Bedingungen, die FDA gelöscht für nur professionellen Gebrauch. Zusätzlich vermarktet die Firma Xact Hilfsmittel-Erste-Hilfeprodukte für im Freiverkehr gehandelte Verkäufe. Die Firma fährt fort, Forschung und die Entwicklung betreffend ist zukünftige Produkte für Lebensstil Verbesserungen zu tun. Quarts 5, Inc. wird im Westlake Dorf, Kalifornien gehabt. Zu mehr Information über die Firma besuchen Sie bitte: (www.qt5inc.com). Sicherer Hafen Dieses Pressekommuniquã© enthält das Vorwärts-Schauen der Aussagen, die Gefahren, Ungewißheiten miteinbeziehen und Annahmen, die, wenn sie nie falsches verwirklichen oder prüfen, die Resultate Quarts 5, Inc. veranlassen konnten, um sich von denen materiell zu unterscheiden, die durch solche Vorwärts-schauende Aussagen ausgedrückt wurden oder angedeutet waren. Alle Aussagen anders als Aussagen über historische Tatsache sind Aussagen, die Vorwärts-schauend Aussagen, einschließlich alle mögliche Projektionen des Einkommens, Einkommen gemeint werden konnten, oder andere finanzielle Einzelteile, irgendwelche Aussagen über die Pläne, Strategien und Zielsetzungen des Managements für zukünftige Betriebe, alle mögliche Aussagen hinsichtlich sind der vorgeschlagenen neuen Produkte, Services oder Entwicklungen, irgendwelche Aussagen betreffend sind zukünftige Wirtschaftslage oder Leistung, Aussagen über Glauben und alle mögliche Aussagen über die Annahmen, die irgendwie vom vorangehenden zugrundeliegend sind. Diese Aussagen basieren auf Erwartungen ab dem Datum dieses Pressekommuniquã©s. Die tatsächlichen Resultate können von denen materiell sich unterscheiden projiziert wegen einer Anzahl von Gefahren und Ungewißheiten, einschließlich die, die von Zeit zu Zeit in den Reports genau geschildert werden, die von QT 5, Inc. mit der Sicherheiten und Austausch-Kommission vorgelegt werden. Quart 5, Inc. nimmt keine Verpflichtung an und beabsichtigt nicht, diese Vorwärts-schauenden Aussagen zu aktualisieren.  

22.06.04 01:16

4388 Postings, 7246 Tage sorosChart

Wie tief gehts noch?

 

    ariva.de


Soros
       

22.06.04 01:28

4388 Postings, 7246 Tage sorosQTFI-Betrügerbude?


Was meint Ihr?



QT 5, Inc. Names Edna T. Barris as Vice President of Sales
WESTLAKE VILLAGE, Calif., April 28, 2004 (PRIMEZONE) -- QT 5, Inc. (OTCBB:QTFI), manufacturer, distributor and marketer of biomedical products, has named Edna T. Barris as Vice President of Sales for all Diagnostic Products. Edna joins QT 5, Inc. with 30 years of Biomedical experience, focused on the sales and introduction of rapid diagnostic products for the last 22 years.

With a B.S. degree in Biological Science and Animal Science from Kansas State University, and graduate studies in their School of Veterinary Medicine, Edna began her career in research at Lederle Laboratories, where she is published in numerous fields.

Prior to joining QT 5, Inc., Ms. Barris was a significant part of the sales, sales training, and sales specialists' team for over a decade with Monoclonal Antibodies, Inc., later to merge with Quidel Corporation. She was instrumental in bringing rapid diagnostic testing into the hospital and POL marketplace with the first sandwich assay tests for pregnancy, ovulation, and infectious disease.

"We are excited to have her on board," said Steven H. Reder, QT 5, Inc. president. "Edna is very well respected in the medical diagnostic fields and has a very impressive group of existing relationships that have already proven invaluable."

About QT 5, Inc.

QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing products. QT 5, Inc. is currently engaged in the development and introduction of Drug Stop, a rapid urinalysis test for drugs of abuse, FDA cleared for professional and over-the-counter use, as well as its Target System(tm) Diagnostic platform that tests for infectious diseases and medical conditions, FDA cleared for professional use only. In addition, the Company markets Xact Aid first-aid products for over-the-counter sales. The company continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: www.qt5inc.com

This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward-looking statements.
 

22.06.04 18:25

4388 Postings, 7246 Tage sorosWatchliste

Börse NASDAQ OTC BBS  

Aktuell 0,035 USD  

Zeit 22.06.04  17:02  

Diff. Vortag +29,63 %  

Tages-Vol. 1.737,50  

Geh. Stück 51.000  



Geld 0,03  

Brief 0,035
 

22.06.04 18:40

4388 Postings, 7246 Tage sorosWas meint Ihr?

chart

http://isht.comdirect.de/charts/...ors=0x000000&sSym=QTFI.NAP&hcmask=

könnte sich langsam aufbauen, step by step und dann beginnt der Herdentrieb?  

22.06.04 18:57

4388 Postings, 7246 Tage sorosauch nett!

ATNG:

Börse NASDAQ OTC BBS  

Aktuell 0,0099 USD  

Zeit 22.06.04  18:40  

Diff. Vortag +102,04 %  

Tages-Vol. 583.997,02  

Geh. Stück 73 Mio.  



Geld 0,0095  

Brief 0,0099  

Zeit 22.06.04  18:36  

Spread 4,0404%  

Geld Stk. 5.000  

Brief Stk. 99.900  



Schluss
Vortag 0,0049  

Eröffnung 0,005  

Hoch 0,0099  

Tief 0,0049  

52W Hoch 0,03  

52W Tief 0,0018
 

22.06.04 19:09

4388 Postings, 7246 Tage sorosbei WO

Würg!


QT 5, INC.

172,666,667 SHARES OF COMMON STOCK
This prospectus covers the resale by selling shareholders of up to 172,666,667 shares of our common stock, $0.001 par value. The selling shareholders are offering:

- 166,666,667 shares of common stock underlying our 10% callable secured convertible notes, and

- 6,000,000 shares of common stock underlying warrants.

These securities are more fully described in the section of this prospectus titled " Description of Securities to be Registered" .

The selling shareholders will sell in accordance with the terms described in the section of this prospectus titled " Plan of Distribution" . We will not receive any of the proceeds from the sale of the shares by the selling shareholders.

Our common stock is listed on the Over-The-Counter Bulletin Board. Our trading symbol is " QTFI."

AN INVESTMENT IN OUR SECURITIES INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD PURCHASE OUR SECURITIES ONLY IF YOU CAN AFFORD A COMPLETE LOSS OF YOUR INVESTMENT. SEE " RISK FACTORS" BEGINNING AT PAGE 2.

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

The date of this prospectus is June __, 2004
 

22.06.04 19:22

3186 Postings, 6428 Tage lancerevo7@soros

atng wollte ich letzte woche kaufen  

22.06.04 21:59

4388 Postings, 7246 Tage sorosotc geht mir aufn Keks!

dauernd nur R-Splits und dann wieder verwässern, so können ja keine normalen Kurse entstehen. (ivhoe,qtfi, exgo...)

ATNG zwar nett, aber kommt wahrscheinlich schnell wieder zurück, wie bei allen OTC Zockerwerten mit Mrd Aktien am Markt. Ist ja mittlerweile wie im Casino. Na ja, ich schaue erstmal nur zu!

Gruß

soros  

23.06.04 13:35

4388 Postings, 7246 Tage soroswas ich merkwürdig finde, ist

das QTFI sich verdammt gut hält. War schon wieder kurz bei 0,04 USD? Ob da ein Investor einsammelt? Also wenn ich mit Innovation Holdings vergleiche, echt stabil bisher der QTFI Kurs. Nachkaufen traue ich mich nicht mehr, befürchte das die wieder verwässern!

http://isht.comdirect.de/charts/...ors=0x000000&sSym=QTFI.NAP&hcmask=


Börse NASDAQ OTC BBS  

Aktuell 0,035 USD  

Zeit 22.06.04  21:58  

Diff. Vortag +29,63 %  

Tages-Vol. 6.976,38  

Geh. Stück 207.825  



Geld 0,03  

Brief 0,04  

Zeit 22.06.04  21:45  

Spread 25%  

Geld Stk. 5.000  

Brief Stk. --  



Schluss
Vortag 0,027  

Eröffnung 0,03  

Hoch 0,04  

Tief 0,03  

 

23.06.04 13:55

205 Postings, 6475 Tage charttechnikmal ein paar zahlen! lol

During the three-months ended March 31, 2004, we had revenues of $1,298 andincurred a net loss of $1,081,677 compared to $0 revenue and a net loss of$3,446,669 during the three-months ended March 31, 2003. Cost of sales for thethree-month period ended March 31, 2004 was $1,075 compared to $0 during thedevelopment stage three-month period ended March 31, 2003. General andadministrative expenses for the three-months ended March 31, 2004 were $891,266compared to $3,372,580 for the three-months ended March 31, 2003. The decreasein expenses of $2,481,314 for the current three-month period were due to adecrease of consulting fees of $3,060,428, which were substantially consulting,legal and professional fees associated with completing our merger, lessincreases for the current period due to salaries of $318,312, professional feesof $179,015 and other operating expenses of approximately $81,787. During thethree-months ended March 31, 2004 and 2003, we recorded interest expense of$121,494 and $74,089, respectively, representing accrued interest andamortization of a discount on convertible debentures.

During the nine months ended March 31, 2004, we had revenues of $191,702 andincurred a net loss of $6,472,968 compared to $0 revenue and a net loss of$4,173,089 during the nine months ended March 31, 2003. Additional shipments tocertain pharmacies in the amount of $269,100 during the current nine-monthperiod, not included as revenue and reflected as deferred revenue, have beenreversed against accounts receivable in our March 31, 2004 balance sheet. Thenine-month period ended March 31, 2003 was part of our development stageactivities.

Cost of sales for the nine-month period ended March 31, 2004 was $109,437compared to $0 during the nine-month development stage period ended March 31,2003. General and administrative expenses for the nine months ended March 31,2004 were $4,307,326 compared to $4,082,616 for the nine months ended March 31,2003. The increase in expenses of $224,710 for the current nine month periodwere due substantially to a reduction in medical, marketing and other advisoryconsulting fees of $ 2,304,898 and increases in legal and accounting fees of $438,594, salaries, commissions and related taxes of $1,067,073, insurance of $230,255, advertising of $375,541, freight, marketing and public relations of$181,601, allowance for uncollectible notes receivable of $139,500 and otheroperating expenses of approximately $ 97,044. During the nine months ended March31, 2004 and 2003, we recorded interest expense of $1,463,200 and $90,473,respectively, representing accrued interest and amortization of a discount onconvertible debentures. Also, during the nine months ended March 31, 2004 wewrote wrote-off $33,957 of accounts receivable from certain customers, $294,039of inventory, $44,854 of unamortized intellectual property, $135,023 of prepaidroyalties, $58,459 in sales, less $31,802 in cost of sales, and $222,258 ofaccrued legal fees all in connection with the loss of our NICOWater(TM) patentwhich occurred as a result of a binding arbitration decision rendered January 8,2004.

 

23.06.04 14:07

4388 Postings, 7246 Tage sorosdanke für die Info!

aber auch scheiße kann hoch fliegen, wie wir mittlerweile alle wissen!(Herdentrieb)

Ich habe nur ein kleines Paket im Depot und lasse mal schön liegen!

Gruß

soros

 

23.06.04 16:31

4388 Postings, 7246 Tage sorosdas Ding steigt step by step

bei lächerlichen Volumen? Gestern 25% mit etwa 6000 USD nur. Heute voll die Popelminiorders?

http://isht.comdirect.de/charts/...ors=0x000000&sSym=QTFI.NAP&hcmask=




Börse NASDAQ OTC BBS  

Aktuell 0,04 USD  

Zeit 23.06.04  16:12  

Diff. Vortag +14,29 %  

Tages-Vol. 217,25  

Geh. Stück 5.519  



Geld 0,03  

Brief --  

Zeit 23.06.04  --  

Spread --  

Geld Stk. 5.000  

Brief Stk. --  



Schluss
Vortag 0,035  

Eröffnung 0,03  

Hoch 0,04  

Tief 0,03  

52W Hoch --  

52W Tief --
 

23.06.04 16:47

4388 Postings, 7246 Tage sorosbin mal gespannt, wie es heute endet?

so muß los...

16:26:49 0,0400  7500  
16:13:36 0,0400  1553  
16:13:24 0,0400  933  
16:13:24 0,0400  933  
16:12:52 0,0400  2488  
16:12:13 0,0400  2489  
16:10:50 0,0400  2490  
15:30:18 0,0370  270  
15:30:16 0,0300  270
 

23.06.04 18:41

4388 Postings, 7246 Tage soroskranke Bude



Börse NASDAQ OTC BBS  

Aktuell 0,03 USD  

Zeit 23.06.04  18:22  

Diff. Vortag -14,29 %  

Tages-Vol. 7.235,58  

Geh. Stück 223.356  



Geld 0,025  

Brief 0,03  

Zeit 23.06.04  18:21  

Spread 16,667%  

Geld Stk. 5.000  

Brief Stk. --
 

24.06.04 00:24

4388 Postings, 7246 Tage soros1 Mio Stücke heute?

Börse NASDAQ OTC BBS  

Aktuell 0,02 USD  

Zeit 23.06.04  21:50  

Diff. Vortag -42,86 %  

Tages-Vol. 24.666,78  

Geh. Stück 1 Mio.  



Geld 0,018  

Brief 0,021  

 

24.06.04 00:47

4388 Postings, 7246 Tage soroseinmal so ein Ding !

Symbol:IACH

http://isht.comdirect.de/charts/...ors=0x000000&sSym=IACH.NAP&hcmask=

:)  

26.06.04 14:31

4388 Postings, 7246 Tage sorosQTFI?

Kann mir einer sagen, ob neue Shares auf den Markt geschmissen werden? Das ist doch nicht normal! Gesamt waren doch nur 20 Mio Shares plaziert? (Split:15:1)


Börse NASDAQ OTC BBS  

Aktuell 0,0105 USD  

Zeit 25.06.04  21:54  

Diff. Vortag -38,24 %  

Tages-Vol. 87.486,88  

Geh. Stück 8,7 Mio.  



Geld 0,0095  

Brief 0,0105  

Zeit 25.06.04  21:32  

Spread 9,5238%  

Geld Stk. 5.000  

Brief Stk. --  



Schluss
Vortag 0,017  

Eröffnung 0,017
 

29.06.04 12:21

4388 Postings, 7246 Tage sorosschon wieder 5,2 Mio Shares?Da wird doch

verwässert!?

Börse NASDAQ OTC BBS  

Aktuell 0,0084 USD  

Zeit 28.06.04  21:57  

Diff. Vortag -20,00 %  

Tages-Vol. 45.403,19  

Geh. Stück 5,2 Mio.  



Geld 0,008  

Brief 0,0088  

Zeit 28.06.04  21:57  

Spread 9,0909%  

Geld Stk. 5.000  

Brief Stk. 5.000  



Schluss
Vortag 0,0105  

Eröffnung 0,012  

Hoch 0,012  

Tief 0,007  

 

30.06.04 11:17

4388 Postings, 7246 Tage soros?

QT 5, Inc. Products on Display at Society for Human Resource Management (SHRM) Conference June 27-30, 2004 in New Orleans
WESTLAKE VILLAGE, Calif., June 25, 2004 (PRIMEZONE) -- QT 5, Inc. (OTCBB:QTFI) will have its Drug Stop and Xact Aid products on display Sunday through Wednesday, June 27-30 at the 56th Annual Society for Human Resource Management Conference to be held at the Ernest N. Morial Convention Center in New Orleans, Louisiana.

The QT 5 team will be set up at Booth No. 3261 in the Convention Center all three days of the conference. Steven Reder, President, remarked "We anticipate that our products, including Xact Aid wound specific first aid kits and our FDA cleared over-the-counter Drug Stop drug screening product should be very well received at the SRHM show for their ease of use and competitive price." Shareholders interested in viewing QT 5, Inc.'s booth can participate in this "open" show by registering on-site at the Convention Center's registration area, or online by going to the official SRHM website: http://www.shrm.org/conferences/annual/.

About QT 5, Inc.

QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing products. QT 5, Inc. is currently engaged in the development and introduction of Drug Stop, a rapid urinalysis test for drugs of abuse, FDA cleared for professional and over-the-counter use, as well as its Target System(tm) Diagnostic platform that tests for infectious diseases and medical conditions, FDA cleared for professional use only. In addition, the Company markets Xact Aid first-aid products for over-the-counter sales. The company continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: http://www.qt5inc.com

This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward-looking statements.
 

07.07.04 15:21

65 Postings, 6474 Tage kurspaausgeflogen

die ganze bude ist leer, nix mehr da, alles wech, leute und ausrüstung, nix mehr zu finden !  

07.07.04 20:35

4388 Postings, 7246 Tage soroswat?

wie was alles leer?:(

05/01/2004 21,436,620 MGFS (Stimmt die Anzahl der Shares noch?)  

12.07.04 19:18

4388 Postings, 7246 Tage soros130% heute?

Börse NASDAQ OTC BBS  

Aktuell 0,0065 USD  

Zeit 12.07.04  18:58  

Diff. Vortag +66,67 %  

Tages-Vol. 119.625,87  

Geh. Stück 18 Mio.  



Geld 0,0065  

Brief 0,0068  

Zeit 12.07.04  18:58  

Spread 4,4118%  

Geld Stk. 5.000  

Brief Stk. --  



Schluss
Vortag 0,0039  

Eröffnung 0,0045  

Hoch 0,009  

Tief 0,0045  

52W Hoch --  

52W Tief --  

   
Split

http://isht.comdirect.de/charts/...ors=0x000000&sSym=QTFI.NAP&hcmask=

Wat da los?  

   Antwort einfügen - nach oben